PDF(Pubmed)
Abstract：
Benign paroxysmal positional vertigo (BPPV) is a common vestibular disorder, predominantly affecting the posterior semicircular canal (PSC), and significantly impacts the quality of life (QoL) of patients. This study assesses the effectiveness of Epley\'s manoeuvre in improving QoL in patients with PSC-BPPV. This prospective analytical study, conducted at a tertiary care centre from January 2021 to December 2022, included 93 adult patients diagnosed with PSC-BPPV via the Dix-Hallpike test. Participants were evaluated using the dizziness handicap inventory (DHI) and visual vertigo analogue score (VAS) at baseline and on days 3, 10, and 30 post-treatments with Epley\'s manoeuvre. Data analysis focused on changes in DHI and VAS scores to assess the impact of treatment. The cohort comprised 58.1% males and 41.9% females, with a significant majority over 50 years of age. Notably, 90% of patients reported improvement by the first follow-up. Both DHI and VAS scores showed a statistically significant decrease over the follow-up period (p < 0.05), indicating a reduction in perceived dizziness and visual vertigo symptoms post-treatment. Epley\'s manoeuvre effectively improves the QoL in patients with PSC-BPPV, as evidenced by significant reductions in DHI and VAS scores. This study contributes to the evidence supporting Epley\'s manoeuvre as a key intervention in PSC-BPPV treatment, emphasizing its role in enhancing patient outcomes in clinical practice.
摘要：
良性阵发性位置性眩晕（BPPV）是一种常见的前庭疾病，主要影响后半规管（PSC），并显著影响患者的生活质量(QoL)。本研究评估了Epley策略改善PSC-BPPV患者QoL的有效性。这项前瞻性分析研究，2021年1月至2022年12月在三级护理中心进行,纳入了通过Dix-Hallpike试验诊断为PSC-BPPV的93例成年患者.在基线和Epley治疗后第3、10和30天，使用头晕障碍量表（DHI）和视觉眩晕模拟评分（VAS）对参与者进行评估。数据分析的重点是DHI和VAS评分的变化，以评估治疗的影响。该队列包括58.1％的男性和41.9％的女性，50岁以上的人占绝大多数。值得注意的是,90％的患者在第一次随访时报告改善。DHI和VAS评分在随访期间均显示出统计学上的显着下降（p<0.05），表明治疗后感觉头晕和视觉眩晕症状减少。Epley的操作有效改善了PSC-BPPV患者的QoL，DHI和VAS评分显著降低证明了这一点。本研究为支持Epley作为PSC-BPPV治疗的关键干预措施的操作提供了证据，强调其在临床实践中提高患者预后的作用。
